share

3-Benzyl-1,2,3,4,5,6-Hexahydro-6,11-Dimethyl-2,6-Methano-3-Benzazocin-8-Ol CAS NO 22185-52-0


Unit Price:

CAS No.:22185-52-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3-Benzyl-1,2,3,4,5,6-Hexahydro-6,11-Dimethyl-2,6-Methano-3-Benzazocin-8-Ol is a complex, multi-cyclic organic compound belonging to the benzazocine class, serving as a key synthetic intermediate in advanced pharmaceutical research and development. Its unique bridged structure makes it a valuable scaffold for medicinal chemists exploring novel therapeutic agents, particularly in the central nervous system (CNS) domain. This high-purity compound is essential for R&D laboratories and pharmaceutical manufacturers focused on developing new active pharmaceutical ingredients (APIs) and fine chemical synthesis.

Application

  • Pharmaceutical Intermediate: A critical building block in the synthesis of novel pharmaceutical candidates, especially those targeting neurological pathways.
  • Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to develop new drugs with potential analgesic or psychoactive properties.
  • Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
  • Organic Synthesis: Employed in advanced multi-step syntheses to construct complex polycyclic molecular architectures.
  • Biochemical Research: Utilized in studies investigating ligand-receptor interactions, particularly with opioid receptor subtypes.
  • Fine Chemical Production: An intermediate in the manufacture of specialized, high-value fine chemicals for research and development.

Basic Information

Product Name 3-Benzyl-1,2,3,4,5,6-Hexahydro-6,11-Dimethyl-2,6-Methano-3-Benzazocin-8-Ol
CAS No. 22185-52-0
Molecular Formula C22H27NO
Molecular Weight 321.46 g/mol
Synonyms 3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol; 8-Hydroxy-3-benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocine; 2,6-Methano-3-benzazocin-8-ol, 3-benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-; Benzazocine derivative 22185-52-0; Potential synthetic opioid intermediate; 3-Benzylhexahydrodimethylmethanobenzazocin-8-ol
EINECS Contact for details

Quality Control

Our 3-Benzyl-1,2,3,4,5,6-Hexahydro-6,11-Dimethyl-2,6-Methano-3-Benzazocin-8-Ol is produced under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot undergoes comprehensive analytical testing, including HPLC for purity assessment and spectroscopic methods for structural confirmation. Certificates of Analysis (COA) detailing all test results are provided with every shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain product integrity.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.